Rep. Kevin Hern Sells Off Kenvue Inc. (NYSE:KVUE) Stock

Key Points

• Rep. Kevin Hern sold $1,001–$15,000 of Kenvue stock on August 5 through the Hern Family Foundation account, along with similarly sized positions in six other companies.
• Kenvue reported quarterly revenue of $3.96 billion, up 3% year over year, but missed analyst estimates for earnings per share and revenue by a small margin. Analysts maintain a consensus “Hold” rating with a $19.27 target price.
• Kenvue’s shares were recently trading near $19.09, while the company declared a $0.21 quarterly dividend, representing a 4.4% annualized yield and a high 95.4% payout ratio.

Representative Kevin Hern (Republican-Oklahoma) recently sold shares of Kenvue Inc. NYSE: KVUE. In a filing disclosed on August 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in Kenvue stock on August 5th. The trade occurred in the Representative's "HERN FAMILY FOUNDATION" account.

Representative Kevin Hern also recently made the following trade(s):

• Sold $1,001 - $15,000 in shares of Diageo NYSE: DEO on 8/5/2026.
• Sold $1,001 - $15,000 in shares of Estee Lauder Companies NYSE: EL on 8/5/2026.
• Sold $1,001 - $15,000 in shares of Organon & Co. NYSE: OGN on 8/5/2026.
• Sold $1,001 - $15,000 in shares of Mondelez International NASDAQ: MDLZ on 8/5/2026.
• Sold $1,001 - $15,000 in shares of Versant NASDAQ: VSNT on 8/5/2026.
• Sold $1,001 - $15,000 in shares of Comcast NASDAQ: CMCSA on 8/5/2026.

Kenvue Trading Up 0.3%

NYSE:KVUE opened at $19.09 on Wednesday. The company has a current ratio of 1.01, a quick ratio of 0.71 and a debt-to-equity ratio of 0.67. The stock has a market capitalization of $36.66 billion, a price-to-earnings ratio of 21.94, a PEG ratio of 1.36 and a beta of 0.47. The firm has a fifty day simple moving average of $18.83 and a two-hundred day simple moving average of $18.12. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $21.95.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.31 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.01). Kenvue had a net margin of 10.76% and a return on equity of 21.22%. The company had revenue of $3.96 billion for the quarter, compared to analyst estimates of $3.97 billion. During the same quarter in the prior year, the company posted $0.29 EPS. Kenvue's revenue for the quarter was up 3.0% on a year-over-year basis. Analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, August 26th. Investors of record on Wednesday, August 12th will be paid a dividend of $0.21 per share. This is a boost from Kenvue's previous quarterly dividend of $0.21. This represents a $0.84 annualized dividend and a yield of 4.4%. The ex-dividend date of this dividend is Wednesday, August 12th. Kenvue's payout ratio is currently 95.40%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. CoreCap Advisors LLC increased its position in Kenvue by 64.9% during the second quarter. CoreCap Advisors LLC now owns 1,502 shares of the company's stock worth $29,000 after buying an additional 591 shares during the period. Montag A & Associates Inc. lifted its stake in Kenvue by 6.3% in the first quarter. Montag A & Associates Inc. now owns 10,156 shares of the company's stock valued at $175,000 after buying an additional 600 shares during the last quarter. Cornerstone Wealth Group LLC boosted its holdings in shares of Kenvue by 5.9% in the first quarter. Cornerstone Wealth Group LLC now owns 10,810 shares of the company's stock valued at $187,000 after acquiring an additional 606 shares during the period. Physician Wealth Advisors Inc. boosted its holdings in shares of Kenvue by 67.5% in the fourth quarter. Physician Wealth Advisors Inc. now owns 1,533 shares of the company's stock valued at $26,000 after acquiring an additional 618 shares during the period. Finally, Mill Creek Capital Advisors LLC grew its position in shares of Kenvue by 0.6% during the fourth quarter. Mill Creek Capital Advisors LLC now owns 124,213 shares of the company's stock worth $2,143,000 after acquiring an additional 701 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Citigroup dropped their price objective on Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 15th. Barclays upped their target price on shares of Kenvue from $18.00 to $19.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 21st. Zacks Research lowered shares of Kenvue from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, July 7th. Weiss Ratings raised shares of Kenvue from a "hold (c-)" rating to a "hold (c)" rating in a research report on Monday, June 15th. Finally, UBS Group cut their price target on shares of Kenvue from $20.00 to $19.00 and set a "neutral" rating on the stock in a report on Tuesday. Three investment analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company. Based on data from MarketBeat, Kenvue presently has a consensus rating of "Hold" and a consensus target price of $19.27.

About Representative Hern

Kevin Hern (Republican Party) is a member of the U.S. House, representing Oklahoma's 1st Congressional District. He assumed office on November 13, 2018. His current term ends on January 3, 2027. Hern (Republican Party) is running for re-election to the U.S. House to represent Oklahoma's 1st Congressional District. He declared candidacy for the 2026 election. Kevin Hern went into business as a McDonald's franchisee in 1999. He acquired 10 McDonald's franchises by 2012. He served on the McDonald's National Leadership Team for 13 years, including the tax policy team, the insurance corporation, and as chairman of the economics team. From 2011 to 2015, he was chairman of the finance committee of the Oklahoma Turnpike Authority.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source